When frostbitten limbs warm up again, blood rushes back into the tissue. With that blood come compounds such as histamines ...
Winrevair lowered death or transplant risk in adults with PAH functional class 3-4 at high risk of dying; all in study may ...
Researchers discover how mitochondria not only produce energy but also influence inflammation.
An independent data monitoring committee has recommended terminating the ZENITH study early based on the results.
Merck , known as MSD outside of the United States and Canada, announced today positive topline results from the Phase 3 ZENITH study evaluating WINREVAIR (sotatercept-csrk) in adults with pulmonary ...
Merck said on Monday its drug, Winrevair, helped significantly reduce the risk of death in patients with a rare condition ...
Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, ...
The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...
Chronic obstructive pulmonary disease, or COPD, is a leading cause of disability and death in the U.S., according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback